{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T12:07:43Z","timestamp":1779192463330,"version":"3.51.4"},"reference-count":58,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T00:00:00Z","timestamp":1778803200000},"content-version":"vor","delay-in-days":14,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","cysticfibrosisjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cystic Fibrosis"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.jcf.2026.05.008","type":"journal-article","created":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:36:07Z","timestamp":1779190567000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cystic fibrosis related diabetes \u2013 viewpoints on three research areas presented at the 20th ECFS basic science conference"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-8741-9987","authenticated-orcid":false,"given":"Joanna","family":"Snowball","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Salem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Malinda","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4532-6421","authenticated-orcid":false,"given":"Scott M.","family":"Blackman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jcf.2026.05.008_bib0001","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the cystic fibrosis related diabetes therapy trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.05.008_bib0002","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.2337\/dc23-0380","article-title":"Cystic fibrosis\u2013related diabetes workshop: research priorities spanning disease pathophysiology, diagnosis, and outcomes","volume":"46","author":"Putman","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.05.008_bib0003","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S2213-2600(23)00324-7","article-title":"Understanding and addressing the needs of people with cystic fibrosis in the era of CFTR modulator therapy","volume":"11","author":"Hisert","year":"2023","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0004","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jcf.2023.02.004","article-title":"Elexacaftor\/tezacaftor\/ivacaftor projected survival and long-term health outcomes in people with cystic fibrosis homozygous for F508del","volume":"22","author":"Lopez","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0005","doi-asserted-by":"crossref","first-page":"3325","DOI":"10.1210\/en.2017-00187","article-title":"CFTR influences beta cell function and insulin secretion through non-cell autonomous exocrine-derived factors","volume":"158","author":"Sun","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/j.jcf.2026.05.008_bib0006","doi-asserted-by":"crossref","first-page":"R131","DOI":"10.1530\/EJE-14-0644","article-title":"Management of endocrine disease: cystic fibrosis-related diabetes: novel pathogenic insights opening new therapeutic avenues","volume":"172","author":"Barrio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/j.jcf.2026.05.008_bib0007","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1007\/s00125-016-3936-1","article-title":"Islet-intrinsic effects of CFTR mutation","volume":"59","author":"Koivula","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.jcf.2026.05.008_bib0008","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms5420","article-title":"Glucose-induced electrical activities and insulin secretion in pancreatic islet 2-cells are modulated by CFTR","volume":"5","author":"Guo","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.05.008_bib0009","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.2337\/db13-0510","article-title":"Genetic modifiers of cystic fibrosis-related diabetes","volume":"62","author":"Blackman","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/j.jcf.2026.05.008_bib0010","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1210\/clinem\/dgz102","article-title":"Genetic modifiers of cystic fibrosis-related diabetes have extensive overlap with type 2 diabetes and related traits","volume":"105","author":"Aksit","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2026.05.008_bib0011","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc23-1411","article-title":"Randomized trial of the insulin- only ilet bionic pancreas for the treatment of cystic fibrosis- related diabetes","volume":"47","author":"Sherwood","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.05.008_bib0012","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.jcf.2022.03.010","article-title":"Obesity in cystic fibrosis: prevalence, trends and associated factors data from the US cystic fibrosis foundation patient registry","volume":"21","author":"Szentpetery","year":"2022","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0013","article-title":"Glucagon-like peptide1 receptor agonist treatment of cystic fibrosis-related diabetes complicated by obesity: a cases series and literature review","volume":"38","author":"Ahmed","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2026.05.008_bib0014","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/j.jpeds.2004.12.039","article-title":"Epidemiology of cystic fibrosis-related diabetes","volume":"146","author":"Marshall","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0015","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1111\/j.1651-2227.2007.00250.x","article-title":"Liver disease as risk factor for cystic fibrosis-related diabetes development","volume":"96","author":"Minicucci","year":"2007","journal-title":"Acta Paediatr Int J Paediatr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0016","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.2337\/dc25-0044","article-title":"Trends in cystic fibrosis\u2013related diabetes epidemiology between 2003 and 2018 from the U.S. Cystic fibrosis foundation patient registry","volume":"48","author":"Kohler","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/j.jcf.2026.05.008_bib0017","article-title":"The role of genetic modifiers, inflammation and CFTR in the pathogenesis of cystic fibrosis related diabetes","volume":"27","author":"Hasan","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/j.jcf.2026.05.008_bib0018","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1210\/jc.2008-2186","article-title":"Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis","volume":"94","author":"Blackman","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/j.jcf.2026.05.008_bib0019","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1164\/rccm.201403-0576OC","article-title":"Diabetes-related mortality in adults with cystic fibrosis: role of genotype and sex","volume":"191","author":"Lewis","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0020","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/jama.2021.9883","article-title":"Trends in prevalence of diabetes and control of risk factors in diabetes among US adults, 1999-2018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA - J Am Med Assoc"},{"key":"10.1016\/j.jcf.2026.05.008_bib0021","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1164\/rccm.201901-0145OC","article-title":"Correlating cystic fibrosis transmembrane conductance regulator function with clinical features to inform precision treatment of cystic fibrosis","volume":"199","author":"McCague","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0022","first-page":"249","article-title":"Abstract 253: lifetime rate of CF-related diabetes in the CFTR2 Study correlates logarithmically with the level of CFTR function and, for severe CFTR genotypes, approaches 100% by age 65","volume":"54","author":"Blackman","year":"2019","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.jcf.2026.05.008_bib0023","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.jcf.2026.05.008_bib0024","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008007","article-title":"Genetic association and transcriptome integration identify contributing genes and tissues at cystic fibrosis modifier loci","volume":"15","author":"Gong","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/j.jcf.2026.05.008_bib0025","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1016\/j.ajhg.2022.09.004","article-title":"Pleiotropic modifiers of age-related diabetes and neonatal intestinal obstruction in cystic fibrosis","volume":"109","author":"Aksit","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.jcf.2026.05.008_bib0026","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.jcf.2024.07.018","article-title":"Association of race and ethnicity with the development of cystic fibrosis-related diabetes","volume":"24","author":"Rayas","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0027","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1038\/s41436-020-01073-x","article-title":"Cystic fibrosis\u2013related diabetes onset can be predicted using biomarkers measured at birth","volume":"23","author":"Lin","year":"2021","journal-title":"Genet Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0028","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.1016\/j.jcf.2019.08.003","article-title":"Cystic fibrosis related diabetes: medical management","volume":"18","author":"Ode","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1183\/16000617.0220-2024","article-title":"20 years of the montreal cystic fibrosis related diabetes screening cohort: key insights","volume":"34","author":"Alexandre-Heymann","year":"2025","journal-title":"Eur Respir Rev"},{"key":"10.1016\/j.jcf.2026.05.008_bib0030","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.clnu.2023.12.017","article-title":"ESPEN-ESPGHAN-ECFS guideline on nutrition care for cystic fibrosis","volume":"43","author":"Wilschanski","year":"2024","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0031","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/j.jcf.2019.01.002","article-title":"Visceral adipose tissue is associated with poor diet quality and higher fasting glucose in adults with cystic fibrosis","volume":"18","author":"Bellissimo","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0032","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.numecd.2015.05.005","article-title":"Glycemic index, glycemic load and glycemic response: an international scientific consensus summit from the international carbohydrate quality consortium (ICQC)","volume":"25","author":"Augustin","year":"2015","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/j.jcf.2026.05.008_bib0033","article-title":"Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials","volume":"374","author":"Chiavaroli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/j.jcf.2026.05.008_bib0034","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1158452","article-title":"Quality of dietary macronutrients is associated with glycemic outcomes in adults with cystic fibrosis","volume":"10","author":"Daley","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0035","doi-asserted-by":"crossref","first-page":"2495","DOI":"10.1016\/j.clnu.2019.11.004","article-title":"Dietary intake in cystic fibrosis and its role in glucose metabolism","volume":"39","author":"Armaghanian","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0036","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2024-092503","article-title":"Low-added sugar dietary intervention study to mitigate glucose intolerance and improve body composition in adults with cystic fibrosis: a protocol of a double-blind, randomised study","volume":"14","author":"Zaveri","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jcf.2026.05.008_bib0037","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2024.1441201","article-title":"Safety and tolerability of a low glycemic load dietary intervention in adults with cystic fibrosis: a pilot study","volume":"11","author":"Scully","year":"2024","journal-title":"Front Nutr"},{"key":"10.1016\/j.jcf.2026.05.008_bib0038","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.jcjd.2024.09.001","article-title":"Cystic fibrosis\u2013related diabetes: a first Canadian clinical practice guideline","volume":"49","author":"Coriati","year":"2025","journal-title":"Can J Diabetes"},{"key":"10.1016\/j.jcf.2026.05.008_bib0039","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.jcf.2023.08.004","article-title":"What do people with cystic fibrosis eat? Diet quality, macronutrient and micronutrient intakes (compared to recommended guidelines) in adults with cystic fibrosis\u2013A systematic review","volume":"22","author":"Greaney","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0040","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jcf.2023.03.011","article-title":"A paradigm shift in cystic fibrosis nutritional care: clinicians\u2019 views on the management of patients with overweight and obesity","volume":"22","author":"Snowball","year":"2023","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0041","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.jcf.2019.01.009","article-title":"The main mechanism associated with progression of glucose intolerance in older patients with cystic fibrosis is insulin resistance and not reduced insulin secretion capacity","volume":"18","author":"Colomba","year":"2019","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0042","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.jcf.2024.08.005","article-title":"Glucagon-like-peptide-1 agonist therapy in adults with cystic fibrosis","volume":"24","author":"Park","year":"2025","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0043","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jcf.2025.10.006","article-title":"Impact of glucagon-like-peptide-1 receptor agonist therapy on pulmonary function in people with cystic fibrosis who achieve normal body mass index","volume":"25","author":"Horvit","year":"2026","journal-title":"J Cyst Fibros"},{"key":"10.1016\/j.jcf.2026.05.008_bib0044","doi-asserted-by":"crossref","DOI":"10.1002\/rcr2.70541","article-title":"Muscle dysfunction and bone loss in a woman with cystic fibrosis and obesity treated with glucagon-like peptide 1 agonist: a case report","volume":"14","author":"Kumar","year":"2026","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.jcf.2026.05.008_bib0045","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell\u2013Derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0046","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/j.stem.2023.04.002","article-title":"Developments in stem cell-derived islet replacement therapy for treating type 1 diabetes","volume":"30","author":"Hogrebe","year":"2023","journal-title":"Cell Stem Cell"},{"key":"10.1016\/j.jcf.2026.05.008_bib0047","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1056\/NEJMoa2503822","article-title":"Survival of transplanted allogeneic beta cells with No immunosuppression","volume":"393","author":"Carlsson","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0048","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/j.jcf.2026.05.008_bib0049","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","article-title":"Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells","volume":"40","author":"Balboa","year":"2022","journal-title":"Nat Biotechnol"},{"key":"10.1016\/j.jcf.2026.05.008_bib0050","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40893-8","article-title":"Deciphering early human pancreas development at the single-cell level","volume":"14","author":"Ma","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.05.008_bib0051","doi-asserted-by":"crossref","DOI":"10.3389\/frtra.2024.1485444","article-title":"Status of islet transplantation and innovations to sustainable outcomes: novel sites, cell sources, and drug delivery strategies","volume":"3","author":"Wong","year":"2024","journal-title":"Front Transplant"},{"key":"10.1016\/j.jcf.2026.05.008_bib0052","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/sctm.18-0033","article-title":"Using mesenchymal stromal cells in islet transplantation","volume":"7","author":"Arzouni","year":"2018","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/j.jcf.2026.05.008_bib0053","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00653-2020","article-title":"Involvement of CFTR in the pathogenesis of pulmonary arterial hypertension","volume":"58","author":"Le Ribeuz","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jcf.2026.05.008_bib0054","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1369\/00221554241299862","article-title":"Hull-Meichle RL. Role of the pancreatic islet microvasculature in health and disease","volume":"72","author":"Aplin","year":"2024","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jcf.2026.05.008_bib0055","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1369\/00221554241236535","article-title":"Diabetes as a pancreatic microvascular disease\u2014a pericytic perspective","volume":"72","author":"Mateus Gon\u00e7alves","year":"2024","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/j.jcf.2026.05.008_bib0056","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11178-w","article-title":"Patient-derived pancreas-on-a-chip to model cystic fibrosis-related disorders","volume":"10","author":"Shik Mun","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/j.jcf.2026.05.008_bib0057","doi-asserted-by":"crossref","DOI":"10.1007\/s11892-020-01357-1","article-title":"Pancreas-on-a-chip technology for transplantation applications","volume":"20","author":"Abadpour","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/j.jcf.2026.05.008_bib0058","doi-asserted-by":"crossref","DOI":"10.1016\/j.jcf.2026.03.021","article-title":"Research updates in cystic fibrosis related diabetes: understanding pathophysiology, expanding animal and human islet models, and advancing clinical and translational research","author":"Putman","year":"2026","journal-title":"J Cyst Fibros"}],"container-title":["Journal of Cystic Fibrosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1569199326001141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,19]],"date-time":"2026-05-19T11:36:15Z","timestamp":1779190575000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1569199326001141"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":58,"alternative-id":["S1569199326001141"],"URL":"https:\/\/doi.org\/10.1016\/j.jcf.2026.05.008","relation":{},"ISSN":["1569-1993"],"issn-type":[{"value":"1569-1993","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cystic fibrosis related diabetes \u2013 viewpoints on three research areas presented at the 20th ECFS basic science conference","name":"articletitle","label":"Article Title"},{"value":"Journal of Cystic Fibrosis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcf.2026.05.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V. on behalf of European Cystic Fibrosis Society.","name":"copyright","label":"Copyright"}]}}